LXQ-217
LXQ-217 is an oral active SHP2 inhibitor with the IC50 of 2.01 μM. LXQ-217 induces apoptosis and inhibits cell growth in vivo and in vitro[1].
Product Specifications
CAS Number
2524718-79-2
UNSPSC
12352005
Target
Apoptosis; SHP2
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lxq-217.html
Solubility
10 mM in DMSO
Smiles
CCOC(C=C1)=CC=C1OC2=CC=C(C3=NN(C=O)C(C4=C(Br)C(Br)=C(O)C(O)=C4)C3)C=C2
Molecular Formula
C24H20Br2N2O5
Molecular Weight
576.23
References & Citations
[1]Sun H, et al. Small Molecule SHP2 Inhibitor LXQ-217 affects Lung Cancer Cell Proliferation in Vitro and in Vivo. Chem Biodivers. Published online February 20, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
QP5706-ec-50ug 50ug
Recombinant Human Pre-mRNA-splicing factor SPF27 Protein, GST, E.coli-50ug
Sign In for Pricing
View Details K3886404 1.0 µg DNA
Sptlc2 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details 
TL500917V 500 µL Each
H2-DMb2 Mouse shRNA Lentiviral Particle (Locus ID 15000)
Sign In for Pricing
View Details 
bs-9291R-APC-Cy5.5 100 µL
MUL1 Polyclonal Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details 035554-ML650 100 µL
FBXO21, CT (FBXO21, FBX21, KIAA0875, F-box only protein 21) (MaxLight 650) discontinued
Sign In for Pricing
View Details